# Ernexa Therapeutics Inc.: Form 8-K/A, filed Sep 1, 2022

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K/A
- Filed: 2022-09-01
- Accepted by EDGAR: Sep 1, 2022, 16:45 ET
- Period: 2022-07-21
- Accession: 0001140361-22-031997
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036122031997/brhc10041542_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036122031997/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036122031997/brhc10041542_8ka.htm

Filed Sep 1, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-031997. Last ingested by Listed: Oct 30, 2026, 14:05 ET. No prices; not investment advice.